Piperazine

Piperazine

SCHEMBL5370033

Br.C1CNCCN1.N.N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL5380983 1.00
Piperazine SCHEMBL5370035 1.00 HIF1A (0.75)
Piperazine SCHEMBL28770106 0.94
Piperazine SCHEMBL886864 0.94
Bromide SCHEMBL3966683 0.94 HIF1A (0.86)
Piperazine SCHEMBL1224331 0.94
Bromide SCHEMBL6017046 0.94 HIF1A (0.86)
Piperazine SCHEMBL1005659 0.94
Piperazine SCHEMBL1005658 0.94 HIF1A (0.86)
Piperazine SCHEMBL632421 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7175818-B2 Extraction of metals with diquaternary ammonium salts LYNNTECH, INC. (US) 2007-02-13 US claimed
WO-2005071121-A1 EXTRACTION OF METALS WITH DIQUATERNARY AMMONIUM SALTS LYNNTECH, INC. (US) 2005-08-04 WO claimed
US-6890496-B2 Extraction of metals with diquaternary amines LYNNTECH, INC. (US) 2005-05-10 US claimed
US-20040200782-A1 Extraction of metals with diquaternary ammonium salts CITY BANK 2004-10-14 US claimed
US-7175818-B2 Extraction of metals with diquaternary ammonium salts LYNNTECH, INC. (US) 2007-02-13 US disclosed